Trevi Therapeutics Competitors and Similar CompaniesClear all

Trevi Therapeutics's competitors and similar companies include Cassava Sciences, Moderna, Hutchison China Meditech and R-Pharm.
Trevi Therapeutics
Trevi Therapeutics
Trevi Therapeutics is a drug development company.
Cassava Sciences
Cassava Sciences
Cassava Sciences (formerly known as Pain Therapeutics) is a clinical-stage biotechnology company that specializes in drug development.
Moderna
Moderna
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
Hutchison China Meditech
Hutchison China Meditech
Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
R-Pharm
R-Pharm
R-Pharm is a pharmaceutical company.
Founding Date
Founding Date
2011
Founding Date
1998
Founding Date
2010
Founding Date
2000
Founding Date
2001
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
New Haven, US HQ
Locations
Austin, US HQ
Locations
Cambridge, US HQ
Melbourne, AU
Paris, FR
München, DE
Tokyo, JP
Seoul, KR
Warszawa, PL
see more
Locations
Shanghai, CN HQ
Beijing, CN
Jiangsu, CN
Shanghai, CN
Shanghai, CN
Hong Kong, HK
Hong Kong, HK
see more
Locations
Moskva, RU HQ
Baku, AZ
Illertissen, DE
Lawrence Township, US
Employees
Employees
1912% increase
Employees
303% increase
Employees
5,8004% increase
Employees
1,811
Employees
462
Valuation ($)
Valuation ($)
223.6 m
Valuation ($)
1.3 b
Valuation ($)
21.2 b
Valuation ($)
3.6 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$1.9b (FY, 2025)
Revenue (est.)
$548.5m (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$868m (FY, 2025)
Cost of goods
$324.4m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$1.1b (FY, 2025)
Gross profit
$224.2m (FY, 2025)
Gross profit
N/A
Net income
Net income
($42.7m) (FY, 2025)
Net income
($91m) (FY, 2025)
Net income
($2.8b) (FY, 2025)
Net income
$435.1m (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 94.1m
Total funding raised
N/A
Total funding raised
$ 1.8b
Total funding raised
$ 100m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Cassava Sciences
HQ
Austin, US
Employees
30↑ 3% increase

Cassava Sciences (formerly known as Pain Therapeutics) is a clinical-stage biotechnology company that specializes in drug development.

View company
Moderna
HQ
Cambridge, US
Employees
5,800↑ 4% increase

Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.

View company
Hutchison China Meditech
HQ
Shanghai, CN
Employees
1,811

Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.

View company
R-Pharm
HQ
Moskva, RU
Employees
462

R-Pharm is a pharmaceutical company.

View company